Dallas, TX, March 27, 2016 --(PR.com
)-- The rising incidence of skin disorders such as melanoma and non-melanoma skin cancer, vascular and pigmented lesions, varicose veins, psoriasis, and acne, coupled with an increasing awareness amongst the patients have triggered the market for both diagnostic and treatment devices in the field of dermatology. In comparison with the U.S., a low incidence rate of melanoma (≤1/100 000) was reported in the East Asian countries that include Taiwan, China, Japan, Korea, Hong Kong, and Singapore. The most common subtype in these countries covers acrallentiginous melanoma, which includes approximately 50% to 58% of cutaneous melanoma. The number of skin cancer cases in Singapore has been increasing. There were 2,819 cases of skin cancer in Singapore between 2008 and 2012, among which 83.0% were Chinese, according to the National Skin Centre, followed by the people from Malaysia recording 4.5% of the cases.
Technological advancements that arise from Europe as well as Asia may surpass the U.S. as the leading market worldwide for dermatology devices. For example, in May 2010, the U.S.-based Cynosure Inc. (U.S.) launched its Elite MPX and Elite aesthetic workstation in the Asian market to increase its sales and presence in the Asian market. The company also received regulatory clearance to distribute devices in the Asian market. Furthermore, in July 2012, Alma Lasers Ltd. (Israel) acquired Quantel Derma GmbH to strengthen its portfolio of FDA & CE-cleared high quality lasers, in order to strengthen its presence in major European and Asian countries.
Another major driver is the increasing demand for aesthetic procedures. With the economic boom witnessed in APAC, there is a tremendous increase in the number of cosmetic procedures being performed. Specialized cosmetic techniques have advanced accordingly and have reached a substantial level of sophistication. In 2012, according to the International Society of Aesthetic Plastic Surgery (ISAPS), South Korea has emerged as the world’s largest market for cosmetic procedures.
The APACdermatology devices market is expected to reach USD 997.6 million by 2022, growing at a CAGR of 11.5% in the forecasted period. The market is expected to experience a prolific growth in the forecasted period due to the high prevalence of skin related disorders. Apart from this the increased funding in healthcare and increased spending and awareness for aesthetic procedures is fueling the growth of this market.
By geography the dermatology devices market is segmented into 10 countries Japan, China, India, South Korea, Malaysia, Indonesia, Vietnam, Singapore, Australia and Rest of the APAC. China dominates the market in 2015 followed by Japan, India and South Korea. While the markets of Japan have reached its maturity China is growing at the highest CAGR of 13.7% in the forecasted period. Based on End-Users the dermatology devices are mostly used in hospitals in 2015 followed by clinics and other segments.
An in-depth profiling of the key players have been conducted, along with the recording of the recent developments (including new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by the companies to sustain and strengthen their positions in the APAC dermatology devices market. The major companies operating in the APAC market are Heine Optotechnik, OptomedOy, FotoFinder Systems, Michelson Diagnostics, Genesis Biosystems, Ellipse A/S , Alma Lasers, Palomar Technologies, GE Healthcare, and Philips Healthcare, 3Gen LLC, Welch Allyn, Carl Zeiss Meditec, Inc., Hitachi, Leica Microsystems, Olympus, Toshiba Medical Systems, and Siemens Medical Systems.